Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human ASAHL/N-acylethanolamine-hydrolyzing Acid A Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF4494
This item is not returnable.
View return policy
Description
ASAHL/N-acylethanolamine-hydrolyzing Acid Amidase Polyclonal specifically detects ASAHL/N-acylethanolamine-hydrolyzing Acid Amidase in Human samples. It is validated for Western Blot, Immunoprecipitation.Specifications
ASAHL/N-acylethanolamine-hydrolyzing Acid Amidase | |
Polyclonal | |
Unconjugated | |
Q02083 | |
NAAA | |
Chinese hamster ovary cell line CHO-derived recombinant human ASAHL/N-acylethanolamine-hydrolyzing Acid A isoform 1 Ser29-Lys359 (Val151Ile) Accession # Q02083 | |
100 μg | |
Primary | |
Detects human ASAHL/N-acylethanolamine-hydrolyzing Acid A in direct ELISAs and Western blots. In Western blots, approximately 25% cross-reactivity with recombinant mouse ASAHL is observed. | |
Human | |
IgG |
Western Blot, Immunoprecipitation | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL | |
Acid ceramidase-like protein, ASAHL, ASAH-like protein, EC 3.5.1.-, NAAA, N-acylethanolamine acid amidase, N-acylethanolamine-hydrolyzing acid amidase, Nacylethanolaminehydrolyzing Acid Amidase, N-acylsphingosine amidohydrolase (acid ceramidase)-like, N-acylsphingosine amidohydrolase-like, PLT | |
Goat | |
Affinity Purified | |
RUO | |
27163 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction